Scripta Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $13.7M

  • Investors
  • 6

Scripta Therapeutics General Information

Description

Developer of therapeutic agents designed to modulate gene regulatory controllers in cells. The company's platform integrates genome-wide screening of transcription factor activity, computational modelling of gene regulatory networks, AI-driven identification of small molecule or biologic modulators, and cell-based functional assays, enabling the pharmaceutical and biotechnology sector to address underlying disease mechanisms, particularly in neurodegenerative or chronic conditions, to pursue disease-modifying treatments rather than only symptom-management approaches.

Contact Information

Website
www.scriptatherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Magdalen Centre
  • Robert Robinson Avenue
  • Oxford OX4 4GA
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • Magdalen Centre
  • Robert Robinson Avenue
  • Oxford OX4 4GA
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Scripta Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 12-Nov-2025 $13.7M Completed Startup
To view Scripta Therapeutics’s complete valuation and funding history, request access »

Scripta Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Scripta Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
AlbionVC Venture Capital Minority
Apollo Health Ventures Venture Capital Minority
Oxford Science Enterprises Venture Capital Minority
Oxford University Innovation Corporation Minority
Parkwalk Advisors Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Scripta Therapeutics FAQs

  • When was Scripta Therapeutics founded?

    Scripta Therapeutics was founded in 2024.

  • Where is Scripta Therapeutics headquartered?

    Scripta Therapeutics is headquartered in Oxford, United Kingdom.

  • What is the size of Scripta Therapeutics?

    Scripta Therapeutics has 5 total employees.

  • What industry is Scripta Therapeutics in?

    Scripta Therapeutics’s primary industry is Drug Discovery.

  • Is Scripta Therapeutics a private or public company?

    Scripta Therapeutics is a Private company.

  • What is Scripta Therapeutics’s current revenue?

    The current revenue for Scripta Therapeutics is .

  • How much funding has Scripta Therapeutics raised over time?

    Scripta Therapeutics has raised $13.7M.

  • Who are Scripta Therapeutics’s investors?

    AlbionVC, Apollo Health Ventures, Oxford Science Enterprises, Oxford University Innovation, and Parkwalk Advisors are 5 of 6 investors who have invested in Scripta Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process